← All trials
NCT03158727
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 30, 2017
- Primary completion
- Mar 1, 2019
- Completion date
- Oct 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 180
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- TiGenixLead sponsor
- Universidad Complutense de MadridCollaborator
- European CommissionCollaborator
- University of AmsterdamCollaborator
- University of LimogesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.